Literature DB >> 14501778

Regional expression of cyclooxygenase isoforms in the rat kidney in complete unilateral ureteral obstruction.

Shyan-Yih Chou1, Hui Cai, David Pai, Mervat Mansour, Paul Huynh.   

Abstract

PURPOSE: The cyclooxygenase (COX) pathway is activated in unilateral ureteral obstruction (UUO), contributing to renal hemodynamic alterations in different regions of the kidney. After the release of 24-hour UUO cortical vasoconstriction occurs but medullary hyperemia is seen. We examined the expression of the 2 COX isoforms COX-1 and COX-2 in different regions of the kidney in rats subjected to UUO.
MATERIALS AND METHODS: Clearance experiments were performed after ureteral obstruction release in rats with 24-hour UUO or sham operated rats. COX-1 and COX-2 expression in the cortex and medulla were examined by Western blot analysis and immunohistochemistry.
RESULTS: After UUO release the glomerular filtration rate and renal plasma flow were markedly lower in post-obstructed kidneys than in contralateral kidneys or in kidneys in sham operated rats (p <0.001). Western blot analysis showed that COX-2/beta-actin in the cortex of the obstructed kidney was 0.28 +/- 0.02 densitometry units, significantly lower than 0.67 +/- 0.12 densitometry units in the contralateral unobstructed kidney. In contrast, COX-2/beta-actin in the outer and inner medullae of the obstructed kidney was 7.85 +/- 1.09 and 2.51 +/- 0.14 densitometry units, significantly greater than 3.03 +/- 0.22 and 0.66 +/- 0.14 densitometry units, respectively, in the contralateral unobstructed kidney. The expression of COX-1/beta-actin in the obstructed kidney was similar to that in the contralateral unobstructed kidney in the cortex and medulla.
CONCLUSIONS: Renal COX-2 expression is markedly altered in UUO. Decreased cortical expression of COX-2 and markedly increased expression in the medulla may contribute to disparate regional hemodynamic alterations in UUO.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14501778     DOI: 10.1097/01.ju.0000082964.24635.15

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Role of COX-2 in unilateral ureteral obstruction: what is new?

Authors:  Tianxin Yang; Chunling Li
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-09

2.  Alteration of renal cyclooxygenase expression due to partial unilateral ureteral obstruction in neonatal.

Authors:  Zhi Qin Li; Yi Zhang; Qi Li; Shu Huan Wu; Chang Yu Sun; Zu Jiang Yu
Journal:  Can Urol Assoc J       Date:  2013-03-21       Impact factor: 1.862

3.  Urinary tract obstruction induces transient accumulation of COX-2-derived prostanoids in kidney tissue.

Authors:  Rikke Nørregaard; Boye L Jensen; Sukru Oguzkan Topcu; Guixian Wang; Horst Schweer; Søren Nielsen; Jørgen Frøkiaer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-10       Impact factor: 3.619

4.  Increased cyclooxygenase-2 expression and prostaglandin E2 production in pressurized renal medullary interstitial cells.

Authors:  Inge Carlsen; Kaitlin E Donohue; Anja M Jensen; Angela L Selzer; Jie Chen; Dix P Poppas; Diane Felsen; Jørgen Frøkiær; Rikke Nørregaard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-07-07       Impact factor: 3.619

5.  Increased COX-2 after ureter obstruction attenuates fibrosis and is associated with EP2 receptor upregulation in mouse and human kidney.

Authors:  Signe S Tofteng; Line Nilsson; Amalie K Mogensen; Rikke Nørregaard; Rolf Nüsing; Mikhail Diatchikhine; Lars Lund; Claus Bistrup; Boye L Jensen; Kirsten Madsen
Journal:  Acta Physiol (Oxf)       Date:  2022-05-20       Impact factor: 7.523

Review 6.  Nonsteroidal Anti-Inflammatory Drugs and the Kidney.

Authors:  Walter H Hörl
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-21

Review 7.  Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney.

Authors:  Rikke Nørregaard; Tae-Hwan Kwon; Jørgen Frøkiær
Journal:  Kidney Res Clin Pract       Date:  2015-11-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.